DVT Prophylaxis Following ORIF Surgery
Low molecular weight heparin (LMWH) is the preferred pharmacological agent for DVT prophylaxis following ORIF surgery, with prophylaxis beginning 6-8 hours postoperatively and continuing for 7-10 days or until full mobilization. 1
Risk Assessment for VTE Following ORIF
The risk of venous thromboembolism (VTE) following orthopedic surgery is significant, with several factors increasing this risk:
- Age ≥65 years (2 points on TESS score) 1
- Lower extremity fractures (2 points on TESS score) 1
- Obesity (BMI >30) (1 point on TESS score) 1
- Limited mobility post-surgery
- History of previous VTE (independent risk factor) 1, 2
According to the TESS score from the 2023 WSES guidelines, patients with scores of 3-6 are at moderate risk, while those with scores of 7-14 are at high risk for VTE 1.
Recommended Prophylaxis Protocol
Timing of Initiation
- Begin prophylaxis 6-8 hours after surgery once hemostasis has been established 1, 3
- Starting earlier than 6 hours post-surgery significantly increases bleeding risk 3
Pharmacological Options
First-line: LMWH (e.g., enoxaparin)
Alternative: Unfractionated Heparin (UFH)
Alternative: Fondaparinux
Duration of Prophylaxis
- Standard duration: 7-10 days or until fully mobile 1, 2
- For hip fracture ORIF: Extended prophylaxis for up to 24-32 additional days is recommended 1, 3
- For major abdominal or pelvic surgery with high-risk features: Consider extended prophylaxis for up to 4 weeks 1
Mechanical Prophylaxis
- Intermittent pneumatic compression (IPC) is preferred over graduated compression stockings 1, 2
- Use as monotherapy only when pharmacological methods are contraindicated due to active bleeding or high bleeding risk 1, 2
- Consider combining mechanical with pharmacological methods for highest-risk patients 1
Special Considerations
Contraindications to Pharmacological Prophylaxis
- Active bleeding
- Coagulopathy
- Hemodynamic instability
- Recent intracranial hemorrhage
- History of heparin-induced thrombocytopenia 2
In these cases, use mechanical prophylaxis until the contraindication resolves 1, 2.
Comparative Efficacy and Safety
- LMWH is superior to UFH in preventing VTE events with fewer bleeding complications 1
- LMWH offers the advantage of once-daily dosing versus twice or three times daily for UFH 5
- Minor hemorrhagic complications like wound hematoma and surgical site bleeding are significantly more common with UFH compared to LMWH 5
Monitoring
- Daily reassessment of VTE and bleeding risk is recommended as risk can change during hospitalization 2
- Routine surveillance with venous compression ultrasonography is not recommended 2
Conclusion
For DVT prophylaxis following ORIF surgery, LMWH starting 6-8 hours postoperatively and continuing for 7-10 days (or longer for hip fractures) represents the optimal approach based on current evidence. Mechanical methods should be added for highest-risk patients or used alone when pharmacological prophylaxis is contraindicated.